Published by Iain Gilbert on 31st October 2024
(Sharecast News) - Bioventix revealed on Thursday that chief financial officer Bruce Hiscock had acquired 333 ordinary shares in the London-listed antibodies development and supply company.
URL: http://www.digitallook.com/dl/news/story/34662038/...